| Dr Robert R Vanderzwaag Jr, MD | |
|
5314 Lincolnway East, Mishawaka, IN 46544-4249 | |
| (574) 256-9032 | |
| (574) 256-9049 |
| Full Name | Dr Robert R Vanderzwaag Jr |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 5314 Lincolnway East, Mishawaka, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811996846 | NPI | - | NPPES |
| 000000692030 | Other | IN | ANTHEM - OSCEOLA |
| 200147150A | Medicaid | IN | |
| 000000109343 | Other | IN | ANTHEM BCBS # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01048973A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert R Vanderzwaag Jr, MD Po Box 1887, Elkhart, IN 46515-1887 Ph: (574) 389-0542 | Dr Robert R Vanderzwaag Jr, MD 5314 Lincolnway East, Mishawaka, IN 46544-4249 Ph: (574) 256-9032 |
News Archive
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Carnegie's educational outreach program, BioEYES, will be the recipient of the 2012 Viktor Hamburger Outstanding Educator Prize from the Society for Developmental Biology.
The American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – is reminding the public that it does not recommend marijuana or other cannabis products for the treatment of glaucoma.
Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
› Verified 5 days ago
Theodore R Neumann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 406, Mishawaka, IN 46545 Phone: 574-335-6580 | |
Dr. Josephine Schimizzi, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1505 South Spring Street, Mishawaka, IN 46544 Phone: 574-255-0726 | |
Dale Dennis Deardorff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 420 W 4th St, Suite 180, Mishawaka, IN 46544 Phone: 574-247-3456 Fax: 574-247-3455 | |
James Mccarrey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 | |
Dr. Jack S. Bartoszek, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 615 Fulmer Rd, Mishawaka, IN 46544 Phone: 574-252-3085 Fax: 574-252-5906 | |
Dr. Lawrence R Curry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 E Mckinley Ave, Mishawaka, IN 46545 Phone: 574-256-2556 Fax: 574-258-4278 | |
Jennifer Anne Pennington, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 Fax: 574-254-7222 |